Combining with DPP-4 inhibitors is generally not recommended, as both drug classes work on the incretin system Adding basal insulin for those with more significant hyperglycaemia, which can be used alongside GLP-1 medications (with careful monitoring for hypoglycaemia) Switching to insulin therapy entirely may be necessary for those with advanced beta cell failure For weight management , when GLP-1 medications don't produce adequate weight loss, alternatives include: Orlistat , a lipase inhibitor that reduces fat absorption, though weight loss is typically modest (2-3 kg on average) Naltrexone-bupropion (Mysimba), which works on appetite centres through different pathways
Injections carry risks including nerve damage, kidney stress, allergic reactions, and in rare cases, liver abnormalities
Moreover, adverse effects were noted in all the people enrolled, which required them to stop taking the medication
DOI: 10.1097/01.NPR.0000000000000430,
Between 2007 and 2016, the FDA found nearly a thousand products marketed as dietary supplements that actually contained active pharmaceutical compounds from prescription drugs
Action anti-ge renforce : les cellules sont stimules pour se rgnrer plus rapidement
